The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Xyralid Hemorrhoidal
Hemorrhoidal Suppositories · COCOA BUTTER 88.5 g/100g; PHENYLEPHRINE HYDROCHLORIDE .26 g/100g · Suppository · Rectal · Innovus Pharmaceuticals, Inc.
NDC 57483-0410-13 · 4 BLISTER PACK in 1 CARTON / 24 g in 1 BLISTER PACK · OTC MONOGRAPH FINAL · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- part346
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Hemorrhoidal Suppositories (Suppository)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Innovus Pharmaceuticals, Inc. | COCOA BUTTER 88.5 g/100g; PHENYLEPHRINE HYDROCHLORIDE .26 g/100g | Jul 15, 2026 | Sep 2, 2026 |
| Neilmed Pharmaceuticals Inc. | PHENYLEPHRINE HYDROCHLORIDE 5 mg/2g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Xyralid Hemorrhoidal — NDC 57483-0410-13," retrieved September 3, 2026, https://drugdashboards.com/drug/57483041013.
Free to cite with attribution — see how the data is put together.